Last reviewed · How we verify
NCT04397198: HYBRIDHEART
The Assessment Of Myocardial Viability Based On CTA/MRI Hybrid Models
trial testing Speckle Tracking echocardiography in Acute Myocardial Infarction in 100 participants. Completed in 1 June 2022.
6 July 2021
Quick facts
| Lead sponsor | Cardio Med Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 6 July 2020 |
| Primary completion | 6 July 2021 |
| Estimated completion | 1 June 2022 |
| Sites | 1 location across Romania |
Drugs / interventions tested
- Speckle Tracking echocardiography
Conditions studied
- Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →
- Myocardial Viability — all drugs for Myocardial Viability →
- Vulnerable Coronary Plaques — all drugs for Vulnerable Coronary Plaques →
- Coronary Stenosis — all drugs for Coronary Stenosis →
Sponsor
Cardio Med Medical Center
Who can join
Adults 18 to 90, any sex, with Acute Myocardial Infarction or Myocardial Viability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of HYBRIDHEART study is to develop new imagistic prototype for a complex evaluation of the myocardial viability by superposing computed tomographic angiographic polar maps of the myocardium with magnetic resonance imaging contractile maps in subjects who suffered an acute myocardial infarction. Moreover, the study will evaluate the association of myocardial viability with the level of inflammatory markers and the percent of myocardial fibrosis, also will correlate the imaging-derived parameters with the inflammatory status of the patients, left ventricular function, ischemic time and major adverse cardiovascular events (MACE) rate.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04397198
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Myocardial Infarction
Currently open trials in the same condition.
- NCT03951467 — Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations · NA · recruiting
- NCT07536802 — Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial · Phase 4 · recruiting
- NCT06947135 — Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury · NA · recruiting
- NCT06515730 — Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction · Phase 4 · recruiting
- NCT07522164 — Acute Myocardial Infarction Clinical Cohort · active not recruiting
Other Cardio Med Medical Center trials
Trials by the same sponsor.
- NCT04680689 — Assessment of Lesion-Associated Myocardial Ischemia Based on Fusion Coronary CT Imaging · completed
- NCT04161378 — Impact of Cardiac Rehabilitation Programs on Left Ventricular Remodeling After Acute Myocardial Infarction - the REHAB T · completed
- NCT03830944 — Inflammation-mediated Coronary Plaque Vulnerability, Myocardial Viability and Ventricular Remodeling · completed
- NCT03757741 — Inflammation, Fibrosis and Risk of Recurrence After Atrial Fibrillation Ablation · completed
- NCT03702764 — Coronary Plaque Geometry and Acute Coronary Syndromes · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04397198 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardio Med Medical Center
- Last refreshed: 2 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04397198.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing